Dr. Raoof is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
16133 Ventura Blvd
340
Encino, CA 91436Phone+1 818-788-5060Fax+1 818-783-8676
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1986 - 1987
Shiraz University of Medical SciencesClass of 1977
Certifications & Licensure
CA State Medical License 1986 - 2025
NJ State Medical License 1986 - 1991
Clinical Trials
- DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis Start of enrollment: 2014 Jan 01
- 12-Week Study of Plecanatide for CIC (The National CIC3 Study) Start of enrollment: 2014 Apr 01
- A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol Start of enrollment: 2014 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsATI-1777, a Topical Jak1/3 Inhibitor, May Benefit Atopic Dermatitis without Systemic Drug Exposure: Results from Preclinical Development and Phase 2a Randomized Contro...Paul Changelian, Canxin Xu, Steve Mnich, Heidi Hope, Kourtney Kostecki
JID Innovations. 2024-03-01 - 20 citationsA Maximum-Use Trial of Ruxolitinib Cream in Adolescents and Adults with Atopic Dermatitis.Robert Bissonnette, Robert S Call, Tooraj Raoof, Zhaoyin Zhu, Swamy Yeleswaram
American Journal of Clinical Dermatology. 2022-05-01 - 19 citationsTapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics.John E. Jett, Michael McLaughlin, Mark S. Lee, Lawrence Charles Parish, Janet DuBois
American Journal of Clinical Dermatology. 2021-10-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
